Table 2.
Patient data and individual lesion extent.
| Neuropathology | Postoperative time | ||||||
|---|---|---|---|---|---|---|---|
| Hip | ERC | PRC | PHC | ITC | |||
| MTLR-1 | Pilomyxoid astrocytoma | 15 years | + | + | + | 0 | 0 |
| MTLR-2 | Hippocampal sclerosis | 13 years | ++ | ++ | ++ | + | ++ |
| MTLR-3 | Hippocampal sclerosis | 14 years | ++ | ++ | ++ | 0 | ++ |
| MTLR-4 | Pilocytic astrocytoma | 18 years | ++ | ++ | ++ | + | ++ |
| MTLR-5 | Hippocampal sclerosis | 18 months | ++ | ++ | ++ | + | +++ |
| MTLR-6 | Neuroepithelial tumor | 14 years | + | ++ | ++ | 0 | 0 |
| MTLR-7 | Hippocampal sclerosis | 17 years | ++ | ++ | ++ | + | ++ |
| MTLR-8 | Hippocampal sclerosis | 17 years | ++ | ++ | ++ | + | +++ |
| MTLR-9 | Hippocampal sclerosis | 11 months | ++ | ++ | ++ | + | +++ |
| MTLR-10 | Pilocytic astrocytoma | 19 years | ++ | ++ | ++ | 0 | 0 |
HIP hippocampus, ERC entorhinal cortex, PRC perirhinal cortex, PHC parahippocampal cortex, ITC inferior temporal cortex, VOL lesion volume (ml), 0 region unaffected, + rostrocaudal lesion extent ≤20 mm, ++ ≤40 mm +++ >40 mm.